Beauty Farm Medical and Health Industry Inc. (stock code: 02373) released a Next Day Disclosure Return dated 23 October 2025, detailing a repurchase of 65,000 shares on the Hong Kong Stock Exchange.

The opening balance on 21 October 2025 was 235,445,068 issued shares (excluding treasury shares) and 350,500 treasury shares. After the repurchase, the total number of issued shares (excluding treasury shares) was 235,380,068, while treasury shares rose to 415,500.

According to the announcement, the highest and lowest repurchase prices were HKD 30.7 and HKD 29.74, respectively, with an aggregate consideration of HKD 1,971,240. The repurchase came under a general mandate authorized on 27 June 2025, which allows up to 23,579,556 shares to be repurchased — representing approximately 0.1762% of the total issued shares at the time of approval.

The announcement also specifies a moratorium on new share issuance or treasury share transactions until 22 November 2025. It confirms that the repurchase adhered to all relevant regulatory requirements and that no material changes have occurred in the previously filed Explanatory Statement dated 4 June 2025.